| JYSB2400153 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-07-16 | | | | | view |
| CXSL2200079 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | New Drug Application | 2022-02-11 | | Shanghai Henlius Biotech Co Ltd | | | view |
| CXSL2101163 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-06-30 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
| JYSB2400036 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-02-28 | | | | | view |
| CYSB2101317 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2022-01-05 | | Innovent Biologics (Suzhou) Co Ltd | | | view |
| JXSL2200099 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | Import Drug Application | 2022-07-02 | | | | | view |
| JXSL0500003 | 贝伐人源化单抗注射液 | bevacizumab | Injection | Biological Products(2) | Import Drug Application | 2005-03-02 | | Roche Pharma (Schweiz) Ltd | Certificate Issued | 2005-12-20 | view |
| CXSS2101016 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(3.3) | New Drug Application | 2021-08-03 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CXSL2300358 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2023-05-19 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2101295 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2021-12-22 | | | | | view |
| JYSZ2100533 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | License Renew | 2021-12-16 | | | | | view |
| CYSB2300202 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-10-31 | | Bio-Thera Solutions Ltd | | | view |
| JXSS1300010 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Import Drug Application | 2013-09-23 | | | Certificate Issued | 2015-07-07 | view |
| CYSB2200052 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-02-21 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2200054 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-02-21 | | Bio-Thera Solutions Ltd | | | view |
| CYSB2200262 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-11-22 | | | | | view |
| CYSB2400103 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2024-05-01 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CYSB2300064 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products | Supplementary Application | 2023-03-23 | | Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group | | | view |
| CYSB2200053 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(原2) | Supplementary Application | 2022-02-21 | | Bio-Thera Solutions Ltd | | | view |
| CXSL2101206 | 贝伐珠单抗注射液 | bevacizumab | Injection | Biological Products(2.2) | New Drug Application | 2021-07-20 | | Suzhou Suncadia Biopharmaceuticals Co Ltd | | | view |
